Mark Leonard Singleton - 24 Mar 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Reporting relationship: SVP & CFO
Issuer ticker: BVS
Reported as of: 24 Mar 2023
Net transaction value: -$7,676
SEC form: 4
Accepted by SEC: 27 Mar 2023, 19:27:14 UTC
Prior SEC filing: 23 Mar 2023
Next SEC filing: 12 Apr 2023
Source filing: View source filing
Reporting owner signature: /s/ Anthony D'Adamio, Attorney-in-Fact

Key filing fact

Mark Leonard Singleton filed Form 4 for Bioventus Inc. (BVS) on 27 Mar 2023.

Key facts

This page summarizes Mark Leonard Singleton's Form 4 filing for Bioventus Inc. (BVS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Mar 2023, 19:27.

Change

Previous filing in this sequence was filed on 23 Mar 2023.
Current net transaction value: -$7,676.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BVS transaction

Class A Common Stock

Sale

Transaction value: $7,676
Shares: -6,044
Change %: -32%
Price: $1.27
Shares after: 12,581
Date: 24 Mar 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 21, 2023 pursuant to a standing Rule 10b5-1 instruction provision in the award agreement, dated March 21, 2022.